Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,059 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
EGFR-TKI Plus Anti-Angiogenic Drugs in EGFR-Mutated Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Clinical Trials.
Conforti F, Pala L, Bagnardi V, Specchia C, Oriecuia C, Marra A, Zagami P, Morganti S, Tarantino P, Catania C, De Marinis F, Queirolo P, De Pas T. Conforti F, et al. Among authors: marra a. JNCI Cancer Spectr. 2020 Jul 29;4(6):pkaa064. doi: 10.1093/jncics/pkaa064. eCollection 2020 Dec. JNCI Cancer Spectr. 2020. PMID: 33344882 Free PMC article. Review.
What therapies are on the horizon for HER2 positive breast cancer?
Viale G, Morganti S, Ferraro E, Zagami P, Marra A, Curigliano G. Viale G, et al. Among authors: marra a. Expert Rev Anticancer Ther. 2019 Sep;19(9):811-822. doi: 10.1080/14737140.2019.1660164. Epub 2019 Aug 28. Expert Rev Anticancer Ther. 2019. PMID: 31448640 Review.
Expression of tumor-associated antigens in breast cancer subtypes.
Curigliano G, Bagnardi V, Ghioni M, Louahed J, Brichard V, Lehmann FF, Marra A, Trapani D, Criscitiello C, Viale G. Curigliano G, et al. Among authors: marra a. Breast. 2020 Feb;49:202-209. doi: 10.1016/j.breast.2019.12.002. Epub 2019 Dec 12. Breast. 2020. PMID: 31869767 Free PMC article.
Master protocols in immuno-oncology: do novel drugs deserve novel designs?
Mazzarella L, Morganti S, Marra A, Trapani D, Tini G, Pelicci P, Curigliano G. Mazzarella L, et al. Among authors: marra a. J Immunother Cancer. 2020 Mar;8(1):e000475. doi: 10.1136/jitc-2019-000475. J Immunother Cancer. 2020. PMID: 32238471 Free PMC article. Review.
HER2-Low Breast Cancer: Pathological and Clinical Landscape.
Tarantino P, Hamilton E, Tolaney SM, Cortes J, Morganti S, Ferraro E, Marra A, Viale G, Trapani D, Cardoso F, Penault-Llorca F, Viale G, Andrè F, Curigliano G. Tarantino P, et al. Among authors: marra a. J Clin Oncol. 2020 Jun 10;38(17):1951-1962. doi: 10.1200/JCO.19.02488. Epub 2020 Apr 24. J Clin Oncol. 2020. PMID: 32330069 Review. No abstract available.
Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis.
Esposito A, Marra A, Bagnardi V, Frassoni S, Morganti S, Viale G, Zagami P, Varano GM, Buccimazza G, Orsi F, Venetis K, Mazzarella L, Viale G, Fusco N, Criscitiello C, Curigliano G. Esposito A, et al. Among authors: marra a. Eur J Cancer. 2021 Mar;145:197-209. doi: 10.1016/j.ejca.2020.12.028. Epub 2021 Jan 22. Eur J Cancer. 2021. PMID: 33493979
1,059 results